Voon H Ong

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

Medicine, Pharmacology, Pharmacotherapy +12

Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis

Svetlana I. Nihtyanova, Benjamin Schreiber, Voon H Ong et al. · Arthritis & Rheumatology · 2014 · 457 citations

Medicine, Clinical Sciences, Internal Medicine +15

Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis

Angelo De Lauretis, Piersante Sestini, Panagiotis Pantelidis et al. · The Journal of Rheumatology · 2013 · 262 citations · Full text

Veterinary Medicine, Immunology, Autoimmunity +16

The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index

Gabriele Valentini, Michele Iudici, Ulrich A. Walker et al. · Annals of the Rheumatic Diseases · 2016 · 234 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis

Korsa Khan, Shiwen Xu, Svetlana I. Nihtyanova et al. · Annals of the Rheumatic Diseases · 2012 · 218 citations

Medicine, Immunology, Pathology +17